ANNA FAULK: Open Payments
NPI 1043784267 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,412 in 220 payments from 33 companies in 2025. Trend: 2023 $2,155 · 2024 $3,201 · 2025 $3,412
Food & beverage: $3,216Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $716 |
| Neurocrine BioSciences, Inc. | 49 | $417 |
| PFIZER INC. | 15 | $228 |
| Teva Pharmaceuticals USA, Inc. | 9 | $206 |
| Janssen Biotech, Inc. | 7 | $185 |
| Lundbeck LLC | 8 | $164 |
| Alexion Pharmaceuticals, Inc. | 7 | $159 |
| EMD Serono, Inc. | 8 | $136 |
| Neurelis, Inc. | 7 | $131 |
| Lilly USA, LLC | 7 | $118 |
Products named: INGREZZA, QULIPTA, NURTEC ODT, UBRELVY, VYEPTI, ULTOMIRIS, BOTOX, VALTOCO.
Industry payments across LA — which companies pay providers there.
